Luca Sangiori | Head of Medical Genetics and Rare Orthopedic Diseases
Rizzoli Orthopaedic Institute

Luca Sangiori, Head of Medical Genetics and Rare Orthopedic Diseases, Rizzoli Orthopaedic Institute

Dr Luca Sangiorgi helds a Medical degree from the University of Bologna, a PhD in Clinical Genetics at “La Sapienza” University of Rome and a Master Degree in Research Promotion and Governance in Hospital Trusts and Local Health Units at the University of Modena and Reggio Emilia.
He has been Visiting Scientist at the Molecular Oncology Section, Paediatric Branch of the National Cancer Institute in Maryland (USA).
He is coordinator of the Rizzoli Rare Disease Center and responsible of four National Registers of Rare Disease (Multiple Hereditary Exostoses, Osteogenesis Imperfecta, Ehrler Danlos and Ollier Disease). He also coordinates the Emilia Romagna Region Hub and Spoke Network on Rare Bone Disorders.
Italian representative in the Assembly of Member States (AoM) of BBMRI (Biobanking and Biomolecular Resources Research Infrastructure) since 2013, he is currently acting as Chair of the AoM and Coordinator of the BBMRI Rare Disease Interest Group.
Since December 2014 he is acting as Alternate of the Representative of Italian Government for the Committee for Advanced Therapies (CAT) of the European Medicine Agency (EMA).
Since March 2017 he is the coordinator of BOND ERN that includes 38 Centres of Excellence for the treatment of Rare Bone Disorders in 10 EU Member States.
As member of many different medical and scientific societies, he has been appointed President of Connective Tissue Oncology Society and International Skeletal Dysplasia Society.

Appearances:



Day 1, Nov 7 @ 08:35

European Reference Networks (ERNs) – What are they expected to deliver?

  • Why ERNs were established, how do they work and what kinds of ERNs are already in place for rare diseases?
  • Creating a clear governance structure for knowledge sharing and coordination across the EU to improve access to diagnosis, treatment and care
  • What resources do ERNs have to reach their goals, at a European and Member State level
last published: 15/Oct/18 14:15 GMT

back to speakers

Follow us on

 

Sign Up for Event Updates

Get Involved At World Orphan Drug Congress 2018

 

To Sponsor Or Exhibit

 

Andrew Mears
andrew.mears@terrapinn.com
t/ +44 20 7092 1228

 

To Speak

 

Wing-Yun Cheung
wing-yun.cheung@terrapinn.com
t/ +44 20 7092 1172

 

To Register

 

Issa Mauthoor
issa.mauthoor@terrapinn.com
t/ +44 20 7092 1257